R&D
Cassava’s Alzheimer’s drug nears P3 readout, but SEC scandal...
Cassava is advancing simufilam through a pivotal phase 3 trial, despite lingering controversy from a SEC investigation.
News
Alligator pancreatic cancer drug 'nearly doubles' survival
Alligator Bioscience has reported updated results with its CD40 agonist mitazalimab as a first-line treatment for advanced pancreatic cancer, a disease with few treatment options.<
News
Beam points to positive data with key base editing asset
It has been around a year since Beam Therapeutics slashed its headcount and R&D programmes to focus mainly on a sickle cell disease candidate – and the biotech has now revealed the firs
R&D
From neurosurgery to focused ultrasound: Not if, but when
Therapeutic or focused ultrasound began being applied to neurologic conditions less than a decade ago, but its potential in a wide spectrum of brain applications is high.
R&D
Partner Content
EHS&S for Biopharma & Pharma Summit
Implementing Corporate & Regulatory-Guided EHS Practices to Achieve Zero Biosafety, Ergonomic & Chemical Incidents for Employee Safety Across Global Facilities
Debates & Insights
News
Press Releases
Editor's Picks
Editor's Picks
